EPO and Glucose intolerance: In the present study, we fed C57BL/6 mice with HFD to establish glucose intolerance and investigated the effects of EPO treatment on glucose tolerance and the potential molecular mechanisms underlying the action of EPO in regulating gluconeogenesis and inflammation in the liver.